Johnson &a; Johnson Innovation – JJDC
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Johnson &a; Johnson Innovation – JJDC Information
Geographic Data
Address: 410 George Street
City: New Brunswick
State: NJ
Zip: 08901
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Johnson & Johnson engages in the manufacture and supply of medical devices, pharmaceutical and consumer packaged goods.
Contact Phone:
+16172254700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2019 | Protekt Therapeutics | Venture Round | 4.1M |
| 12/2020 | ONL Therapeutics | Series B | 0 |
| 10/2020 | Datavant | Series B | 40M |
| 10/2018 | CuraSen Therapeutics | Series A | 54.5M |
| 7/2018 | S-Biomedic | Series A | 0 |
| 6/2021 | Thirty Madison | Series C | 0 |
| 1/2020 | AviadoBio | Seed Round | 15.9M |
| 2/2018 | Syndesi Therapeutics | Series A | 21.3M |
| 9/2020 | Syndesi Therapeutics | Series A | 7M |
| 9/2022 | DocSpera | Series B | 10M |
| 9/2020 | ESCAPE Bio | Venture Round | 73M |
| 3/2022 | Rondo Therapeutics | Series A | 0 |
| 8/2020 | ImmPACT Bio | Series A | 0 |
| 12/2021 | AviadoBio | Series A | 0 |
| 9/2018 | PhaseBio Pharmaceuticals | Series D | 0 |
| 3/2021 | Visus Therapeutics | Series A | 36M |
| 12/2022 | HistoSonics | Convertible Note | 85M |
| 3/2022 | TRex Bio | Series A | 0 |
| 1/2019 | Ribon Therapeutics | Series B | 65M |
| 7/2021 | Point Biopharma | Post-IPO Equity | 0 |
| 7/2015 | Protagonist Therapeutics | Series C | 0 |
| 5/2019 | Cala Health | Series C | 0 |
| 8/2020 | Thirty Madison | Series B | 47M |
| 1/2022 | Verana Health | Series E | 0 |
| 6/2021 | Ribon Therapeutics | Series C | 0 |
| 6/2023 | Astraveus | Seed Round | 0 |
| 6/2019 | BlackThorn Therapeutics | Series B | 76M |
| 1/2022 | Iterative Scopes | Series B | 0 |
| 3/2021 | TechsoMed | Series B | 7M |
| 12/2022 | Pulmocide | Series C | 0 |
| 8/2021 | Iterative Scopes | Series A | 0 |
| 11/2017 | On Target Laboratories | Series B | 40M |
| 12/2019 | Mauna Kea Technologies | Post-IPO Equity | 8.4M |
| 9/2020 | V-Wave | Series C | 0 |
| 3/2021 | Sunday2Sunday | Series A | 0 |
| 2/2019 | Vor Biopharma | Series A | 42M |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 8/2020 | G.I. Windows | Series A | 0 |
| 7/2020 | Vor Biopharma | Series B | 0 |
| 1/2019 | Memebox | Series D | 39.5M |
| 7/2019 | X-Vax Technology | Series A | 0 |
| 6/2020 | Cue | Series C | 102.6M |
| 7/2018 | OrthoSpin | Venture Round | 3M |
| 4/2020 | RefleXion Medical | Series D | 0 |
| 1/2023 | Perceive Biotherapeutics | Series B | 0 |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 10/2018 | Carrot | Venture Round | 25M |
| 3/2022 | RefleXion Medical | Venture Round | 0 |
| 9/2021 | Mauna Kea Technologies | Post-IPO Equity | 14.7M |
| 6/2020 | HistoSonics | Series C | 40M |
| 5/2018 | NeuroVision Imaging | Series C | 0 |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 8/2021 | Visus Therapeutics | Equity | 20M |
| 3/2023 | Rapport Therapeutics | Series A | 0 |
| 8/2021 | FlexDex | Venture Round | 0 |
| 12/2018 | MultiScale Health Networks | Venture Round | - |
| 4/2021 | Mestag | Seed Round | 11M |
| 12/2022 | SonoThera | Series A | 0 |
| 9/2020 | Sunday2Sunday | Seed Round | - |
| 3/2020 | OrthoSpin | Series B | 5M |
| 5/2019 | TechsoMed | Venture Round | 2.6M |
| 8/2014 | Cala Health | Series A | 3.3M |
| 6/2019 | Cara Care | Series A | 7M |
| 8/2020 | Aetion | Series B | 19M |
| 3/2017 | Pulmocide | Series B | 30.4M |
| 5/2020 | GATT Technologies | Series B | 11.5M |
| 1/2021 | Paige | Series C | 125M |
| 5/2021 | Pulmocide | Series C | 0 |
| 5/2021 | Cue | Venture Round | 235M |
| 3/2022 | RefleXion Medical | Venture Round | 0 |
| 3/2022 | TRex Bio | Series A | 0 |
| 3/2022 | Rondo Therapeutics | Series A | 0 |
| 1/2022 | Iterative Scopes | Series B | 0 |
| 1/2022 | Verana Health | Series E | 0 |
| 12/2021 | AviadoBio | Series A | 0 |
| 9/2021 | Mauna Kea Technologies | Post-IPO Equity | 0 |
| 8/2021 | FlexDex | Venture Round | 0 |
| 8/2021 | Visus Therapeutics | Debt Financing | 0 |
| 8/2021 | Iterative Scopes | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
